TUCSON, Ariz.--(BUSINESS WIRE)--Critical Path Institute (C-Path), an Arizona-based non-profit organization dedicated to fostering collaborative initiatives to improve the quality and efficiency of the drug development process, has received a new multi-year grant from the Bill & Melinda Gates Foundation. This grant will fund the creation and implementation of the Rapid Drug Susceptibility Test Data Platform. The platform will catalog a vast amount of tuberculosis genomic data of worldwide tuberculosis strains. Tuberculosis is the second leading cause of death (after HIV) from a single infectious agent.
Help employers find you! Check out all the jobs and post your resume.
